Integral Diagnostics Limited

ASX:IDX.AX

3.03 (AUD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q2
Revenue 238.444231.253224.398215.701178.244180.495178.098170.71142.253131.828116.647115.34195.82293.57791.15888.57486.11581.65580.75670.457
Cost of Revenue 185.558180.102173.843168.495136.628137.205133.965115.95899.83792.58678.35269.33960.29757.86558.41156.01652.58551.18649.22643.26
Gross Profit 52.88651.15150.55547.20641.61643.2944.13354.75242.41639.24238.29546.00235.52535.71232.74732.55833.5330.46931.5327.197
Gross Profit Ratio 0.2220.2210.2250.2190.2330.240.2480.3210.2980.2980.3280.3990.3710.3820.3590.3680.3890.3730.390.386
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 00000000000000000000
Selling & Marketing Expenses 00000000000000000000
SG&A 30.62831.24128.75829.54725.1923.28422.76721.94117.83217.28720.0911.99110.59410.33710.1089.59.038.758.4297.737
Other Expenses -0.4820.3790.8670.2441.1551.03600000000000000
Operating Expenses 30.14630.86227.89129.30324.03522.24822.76721.94117.83217.28720.0927.55123.82723.00622.27419.43920.41924.24219.14624.684
Operating Income 22.7420.28922.66417.90317.58121.04221.36632.81124.58421.95518.20519.46714.43514.02711.76911.91913.91612.59213.27711.796
Operating Income Ratio 0.0950.0880.1010.0830.0990.1170.120.1920.1730.1670.1560.1690.1510.150.1290.1350.1620.1540.1640.167
Total Other Income Expenses Net -14.108-85.996-10.3960.79-10.204-5.7-4.987-3.986-5.117-6.162-3.142-3.912-3.921-2.434-2.316-0.063-2.525-7.533-2.424-11.708
Income Before Tax 8.632-65.70712.26818.6937.37715.34216.37928.82519.46715.79315.06315.55510.51411.5939.45311.85611.3915.05910.8530.088
Income Before Tax Ratio 0.036-0.2840.0550.0870.0410.0850.0920.1690.1370.120.1290.1350.110.1240.1040.1340.1320.0620.1340.001
Income Tax Expense 2.5750.9893.2472.3462.9355.0235.0158.9397.3144.9134.7344.9013.6863.3422.6353.1943.7821.283.2682.868
Net Income 6.057-66.7568.90316.1374.40310.211.37219.89612.15310.8810.32910.6546.8288.2516.8188.6627.6093.7797.392-2.892
Net Income Ratio 0.025-0.2890.040.0750.0250.0570.0640.1170.0850.0830.0890.0920.0710.0880.0750.0980.0880.0460.092-0.041
EPS 0.026-0.290.0380.0690.0190.050.0570.10.0620.0610.0640.0680.0470.0570.0470.060.0530.0280.059-0.026
EPS Diluted 0.026-0.290.0380.0690.0190.050.0550.0980.0610.0610.0630.0680.0470.0570.0470.060.0530.0280.059-0.026
EBITDA 46.756-31.44444.18848.62432.08137.8238.92950.09838.3831.11924.87826.29119.12417.80615.72918.25218.36716.86117.84915.83
EBITDA Ratio 0.1960.1870.20.1820.2070.2130.2210.2920.2740.2520.2130.2280.20.2020.1830.190.2130.2060.2210.225